Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on Invested CapitalReturn on SalesTimes Interest Earned

Burning Rock Biotech (BNR) Gross Margin (2020 - 2025)

Historic Gross Margin for Burning Rock Biotech (BNR) over the last 6 years, with Q3 2025 value amounting to 75.1%.

  • Burning Rock Biotech's Gross Margin rose 37000.0% to 75.1% in Q3 2025 from the same period last year, while for Sep 2025 it was 73.03%, marking a year-over-year increase of 43100.0%. This contributed to the annual value of 70.25% for FY2024, which is 26700.0% up from last year.
  • Latest data reveals that Burning Rock Biotech reported Gross Margin of 75.1% as of Q3 2025, which was up 37000.0% from 72.77% recorded in Q2 2025.
  • In the past 5 years, Burning Rock Biotech's Gross Margin registered a high of 75.1% during Q3 2025, and its lowest value of 63.13% during Q2 2022.
  • In the last 5 years, Burning Rock Biotech's Gross Margin had a median value of 70.89% in 2021 and averaged 69.89%.
  • Its Gross Margin has fluctuated over the past 5 years, first tumbled by -77700bps in 2022, then surged by 64500bps in 2024.
  • Quarter analysis of 5 years shows Burning Rock Biotech's Gross Margin stood at 71.52% in 2021, then dropped by 0bps to 71.2% in 2022, then fell by -9bps to 64.51% in 2023, then grew by 10bps to 70.96% in 2024, then rose by 6bps to 75.1% in 2025.
  • Its Gross Margin stands at 75.1% for Q3 2025, versus 72.77% for Q2 2025 and 73.18% for Q1 2025.